These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 33905760)

  • 1. Essential concepts for interpreting the dose-response of low-level arsenic exposure in epidemiological studies.
    Tsuji JS; Lennox KP; Watson HN; Chang ET
    Toxicology; 2021 Jun; 457():152801. PubMed ID: 33905760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A review of low-dose arsenic risks and human cancers.
    Lamm SH; Boroje IJ; Ferdosi H; Ahn J
    Toxicology; 2021 May; 456():152768. PubMed ID: 33781801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic exposure and bladder cancer: quantitative assessment of studies in human populations to detect risks at low doses.
    Tsuji JS; Alexander DD; Perez V; Mink PJ
    Toxicology; 2014 Mar; 317():17-30. PubMed ID: 24462659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-response for assessing the cancer risk of inorganic arsenic in drinking water: the scientific basis for use of a threshold approach.
    Tsuji JS; Chang ET; Gentry PR; Clewell HJ; Boffetta P; Cohen SM
    Crit Rev Toxicol; 2019 Jan; 49(1):36-84. PubMed ID: 30932726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian benchmark dose analysis for inorganic arsenic in drinking water associated with bladder and lung cancer using epidemiological data.
    Shao K; Zhou Z; Xun P; Cohen SM
    Toxicology; 2021 May; 455():152752. PubMed ID: 33741492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arsenic risk assessment.
    Carlson-Lynch H; Beck BD; Boardman PD
    Environ Health Perspect; 1994 Apr; 102(4):354-6. PubMed ID: 7503825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of low-level arsenic exposure in drinking water with cardiovascular disease: a systematic review and risk assessment.
    Tsuji JS; Perez V; Garry MR; Alexander DD
    Toxicology; 2014 Sep; 323():78-94. PubMed ID: 24953689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of arsenic-induced internal cancer at long-term low dose exposure.
    Liao CM; Shen HH; Chen CL; Hsu LI; Lin TL; Chen SC; Chen CJ
    J Hazard Mater; 2009 Jun; 165(1-3):652-63. PubMed ID: 19062162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative assessment of lung and bladder cancer risk and oral exposure to inorganic arsenic: Meta-regression analyses of epidemiological data.
    Lynch HN; Zu K; Kennedy EM; Lam T; Liu X; Pizzurro DM; Loftus CT; Rhomberg LR
    Environ Int; 2017 Sep; 106():178-206. PubMed ID: 28625818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Physiologically based pharmacokinetic modeling of arsenic in the mouse.
    Gentry PR; Covington TR; Mann S; Shipp AM; Yager JW; Clewell HJ
    J Toxicol Environ Health A; 2004 Jan; 67(1):43-71. PubMed ID: 14668111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of mode of action data to inform a dose-response assessment for bladder cancer following exposure to inorganic arsenic.
    Gentry PR; Yager JW; Clewell RA; Clewell HJ
    Toxicol In Vitro; 2014 Oct; 28(7):1196-205. PubMed ID: 24937311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk and revisionism in arsenic cancer risk assessment.
    Mushak P; Crocetti AF
    Environ Health Perspect; 1995; 103(7-8):684-9. PubMed ID: 7588479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arsenic, drinking water, and health: a position paper of the American Council on Science and Health.
    Brown KG; Ross GL;
    Regul Toxicol Pharmacol; 2002 Oct; 36(2):162-74. PubMed ID: 12460751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-level arsenic exposure and developmental neurotoxicity in children: A systematic review and risk assessment.
    Tsuji JS; Garry MR; Perez V; Chang ET
    Toxicology; 2015 Nov; 337():91-107. PubMed ID: 26388044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utility of recent studies to assess the National Research Council 2001 estimates of cancer risk from ingested arsenic.
    Gibb H; Haver C; Gaylor D; Ramasamy S; Lee JS; Lobdell D; Wade T; Chen C; White P; Sams R
    Environ Health Perspect; 2011 Mar; 119(3):284-90. PubMed ID: 21030336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bladder/lung cancer mortality in Blackfoot-disease (BFD)-endemic area villages with low (<150 μg/L) well water arsenic levels--an exploration of the dose-response Poisson analysis.
    Lamm SH; Robbins SA; Zhou C; Lu J; Chen R; Feinleib M
    Regul Toxicol Pharmacol; 2013 Feb; 65(1):147-56. PubMed ID: 23137931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bladder cancer and arsenic through drinking water: a systematic review of epidemiologic evidence.
    Christoforidou EP; Riza E; Kales SN; Hadjistavrou K; Stoltidi M; Kastania AN; Linos A
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2013; 48(14):1764-75. PubMed ID: 24007431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arsenic toxicity at low doses: epidemiological and mode of action considerations.
    Schoen A; Beck B; Sharma R; Dubé E
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):253-67. PubMed ID: 15276404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Systematic Review and Meta-Regression Analysis of Lung Cancer Risk and Inorganic Arsenic in Drinking Water.
    Lamm SH; Ferdosi H; Dissen EK; Li J; Ahn J
    Int J Environ Res Public Health; 2015 Dec; 12(12):15498-515. PubMed ID: 26690190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Research approaches to address uncertainties in the risk assessment of arsenic in drinking water.
    Hughes MF; Kenyon EM; Kitchin KT
    Toxicol Appl Pharmacol; 2007 Aug; 222(3):399-404. PubMed ID: 17379267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.